DMCA
Full list...
Cached
Download Links
BibTeX
@MISC{Rieg_fulllist...,
author = {Siegbert Rieg and Sabine Schmoldt and Christian Theilacker and Katja De and Silke Wölfel and Winfried V Kern and Gerhard Dobler},
title = {Full list...},
year = {}
}
Share
 |
 |
 |
 |
||
OpenURL
Abstract
Background: Tick-borne lymphadenopathy (TIBOLA) was first described in 1997 in a patient in France. The causative agent, Rickettsia slovaca, is transmitted by Dermacentor ticks. Case presentation: In southwestern Germany we encountered a patient with a tick bite at the dorsal scalp that resulted in an eschar and nuchal lymphadenopathy. Additionally, fever, malaise as well as elevated inflammatory markers and transaminases occurred. The characteristic clinical picture along with positive antibody testing for rickettsiae of the tick-borne spotted fever group strongly suggest the diagnosis TIBOLA. Conclusion: Human rickettsioses are emerging infections. Clinicians should be aware of TIBOLA as a newly described rickettsial disease. As in our case, TIBOLA may be encountered in regions/countries where R. slovaca and Dermacentor ticks are prevalent but autochthonous acquisition was not described before. Background Rickettsiae are obligate intracellular gram negative bacteria transmitted in the natural environment by vectors such as ticks, fleas, lice, and mites. Of medical importance are Rickettsiae of the typhus group (R. prowazekii,
Keyphrases
full list dermacentor tick autochthonous acquisition case presentation background rickettsia medical importance human rickettsioses tick-borne lymphadenopathy region country obligate intracellular gram negative bacteria rickettsial disease inflammatory marker characteristic clinical picture typhus group natural environment diagnosis tibola tick bite rickettsia slovaca nuchal lymphadenopathy southwestern germany positive antibody tick-borne spotted fever group causative agent
